🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 18 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/03/1978 | 1,37 | 1,37 | 1,36 | 1,36 | -0,97% | 1,21% | 1.407.254 |
| 03/03/1978 | 1,38 | 1,38 | 1,36 | 1,37 | -0,48% | 1,44% | 1.656.259 |
| 02/03/1978 | 1,39 | 1,39 | 1,37 | 1,38 | -1,42% | 1,67% | 1.859.990 |
| 01/03/1978 | 1,39 | 1,41 | 1,39 | 1,40 | +0,24% | 1,43% | 1.520.438 |
| 28/02/1978 | 1,40 | 1,40 | 1,38 | 1,39 | -1,17% | 1,42% | 913.018 |
| 27/02/1978 | 1,41 | 1,43 | 1,41 | 1,41 | -0,23% | 1,41% | 1.033.747 |
| 24/02/1978 | 1,41 | 1,42 | 1,41 | 1,41 | +0,94% | 0,94% | 1.071.475 |
| 23/02/1978 | 1,40 | 1,40 | 1,39 | 1,40 | -0,23% | 0,71% | 1.501.574 |
| 22/02/1978 | 1,42 | 1,42 | 1,40 | 1,40 | -0,93% | 1,17% | 2.108.995 |
| 21/02/1978 | 1,42 | 1,42 | 1,40 | 1,42 | +0,00% | 0,93% | 1.712.851 |
| 17/02/1978 | 1,44 | 1,45 | 1,41 | 1,42 | -1,38% | 2,54% | 1.592.122 |
| 16/02/1978 | 1,45 | 1,45 | 1,43 | 1,44 | -0,92% | 1,60% | 4.700.909 |
| 15/02/1978 | 1,47 | 1,48 | 1,45 | 1,45 | -1,57% | 1,80% | 2.248.589 |
| 14/02/1978 | 1,48 | 1,49 | 1,47 | 1,47 | -0,67% | 0,89% | 1.048.838 |
| 13/02/1978 | 1,48 | 1,48 | 1,47 | 1,48 | +0,22% | 0,67% | 1.063.930 |
| 10/02/1978 | 1,49 | 1,49 | 1,47 | 1,48 | -0,44% | 1,11% | 3.354.019 |
| 09/02/1978 | 1,50 | 1,50 | 1,49 | 1,49 | -1,10% | 0,89% | 852.653 |
| 08/02/1978 | 1,48 | 1,51 | 1,48 | 1,50 | +1,57% | 1,56% | 1.048.838 |
| 07/02/1978 | 1,48 | 1,49 | 1,47 | 1,48 | +0,22% | 0,89% | 2.025.994 |
| 06/02/1978 | 1,48 | 1,48 | 1,47 | 1,48 | +0,00% | 0,68% | 996.019 |
| 03/02/1978 | 1,47 | 1,48 | 1,47 | 1,48 | +0,22% | 0,67% | 939.427 |
| 02/02/1978 | 1,47 | 1,48 | 1,46 | 1,47 | +0,22% | 1,58% | 1.863.763 |
| 01/02/1978 | 1,45 | 1,47 | 1,45 | 1,47 | +1,14% | 1,37% | 1.678.896 |
| 31/01/1978 | 1,46 | 1,47 | 1,44 | 1,45 | -0,45% | 1,58% | 1.369.526 |
| 30/01/1978 | 1,44 | 1,46 | 1,43 | 1,46 | +1,61% | 1,84% | 1.211.069 |
| 27/01/1978 | 1,44 | 1,46 | 1,43 | 1,44 | -0,46% | 2,29% | 1.252.570 |
| 26/01/1978 | 1,46 | 1,48 | 1,44 | 1,44 | -1,13% | 2,49% | 1.859.990 |
| 25/01/1978 | 1,47 | 1,47 | 1,46 | 1,46 | -0,68% | 0,68% | 1.237.478 |
| 24/01/1978 | 1,47 | 1,47 | 1,46 | 1,47 | +0,00% | 1,13% | 2.893.738 |
| 23/01/1978 | 1,46 | 1,48 | 1,46 | 1,47 | +0,46% | 1,36% | 928.109 |